ROCHE HOLDING AG (1ROG.MI) Stock Price & Overview
BIT:1ROG • CH1499059983
Current stock price
The current stock price of 1ROG.MI is 342.8 EUR. Today 1ROG.MI is down by -5.15%. In the past month the price increased by 0.07%.
1ROG.MI Key Statistics
- Market Cap
- 277.411B
- P/E
- 16.14
- Fwd P/E
- 15.66
- EPS (TTM)
- 21.24
- Dividend Yield
- 3.09%
1ROG.MI Stock Performance
1ROG.MI Stock Chart
1ROG.MI Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to 1ROG.MI.
1ROG.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 1ROG.MI. Both the health and profitability get an excellent rating, making 1ROG.MI a very profitable company, without any liquidiy or solvency issues.
1ROG.MI Earnings
On January 29, 2026 1ROG.MI reported an EPS of 8.53 and a revenue of 30.57B. The company missed EPS expectations (-3.53% surprise) and missed revenue expectations (-3.25% surprise).
1ROG.MI Forecast & Estimates
27 analysts have analysed 1ROG.MI and the average price target is 407.15 EUR. This implies a price increase of 18.77% is expected in the next year compared to the current price of 342.8.
For the next year, analysts expect an EPS growth of 3.06% and a revenue growth 1.15% for 1ROG.MI
1ROG.MI Groups
Sector & Classification
1ROG.MI Financial Highlights
Over the last trailing twelve months 1ROG.MI reported a non-GAAP Earnings per Share(EPS) of 21.24. The EPS increased by 4.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.94% | ||
| ROA | 12.79% | ||
| ROE | 38.1% | ||
| Debt/Equity | 0.85 |
1ROG.MI Ownership
1ROG.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1SAN | SANOFI | 8.82 | 97.096B | ||
| SNW | SANOFI | 8.82 | 97.084B | ||
| SAN | SANOFI | 8.82 | 97.071B | ||
| MRK | MERCK KGAA | 14.19 | 48.652B | ||
| UNC | UCB SA | 22.97 | 47.169B | ||
| UCB | UCB SA | 22.63 | 46.488B | ||
| 1BAYN | BAYER AG-REG | 9.09 | 39.267B | ||
| BAYN | BAYER AG-REG | 8.75 | 37.823B | ||
| IPN | IPSEN | 12.88 | 13.661B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 16.66 | 10.352B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.089B | ||
| VIRP | VIRBAC SA | 17.7 | 3.176B | ||
| DMP | DERMAPHARM HOLDING SE | 18.51 | 2.46B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1ROG.MI
Company Profile
Roche Holding AG is a CH-based company operating in Pharmaceuticals industry. The company is headquartered in Basel, Basel-Stadt and currently employs 112,774 full-time employees. The company went IPO on 2001-05-04. Roche Holding AG (Roche) is a research-based healthcare company. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Company Info
IPO: 2001-05-04
ROCHE HOLDING AG
Grenzacherstr. 124
Basel BASEL-STADT CH
Employees: 112774
Phone: 41616881111
ROCHE HOLDING AG / 1ROG.MI FAQ
Can you describe the business of ROCHE HOLDING AG?
Roche Holding AG is a CH-based company operating in Pharmaceuticals industry. The company is headquartered in Basel, Basel-Stadt and currently employs 112,774 full-time employees. The company went IPO on 2001-05-04. Roche Holding AG (Roche) is a research-based healthcare company. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
What is the current price of 1ROG stock?
The current stock price of 1ROG.MI is 342.8 EUR. The price decreased by -5.15% in the last trading session.
Does 1ROG stock pay dividends?
ROCHE HOLDING AG (1ROG.MI) has a dividend yield of 3.09%. The yearly dividend amount is currently 0.
How is the ChartMill rating for ROCHE HOLDING AG?
1ROG.MI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the analyst forecast for 1ROG.MI stock?
27 analysts have analysed 1ROG.MI and the average price target is 407.15 EUR. This implies a price increase of 18.77% is expected in the next year compared to the current price of 342.8.
Can you provide the sector and industry classification for ROCHE HOLDING AG?
ROCHE HOLDING AG (1ROG.MI) operates in the Health Care sector and the Pharmaceuticals industry.
Can you provide the PE ratio for 1ROG stock?
The PE ratio for ROCHE HOLDING AG (1ROG.MI) is 16.14. This is based on the reported non-GAAP earnings per share of 21.24 and the current share price of 342.8 EUR.